Pliant Therapeutics, Inc.

This study tested whether a new drug called PLN-74809 could reduce the buildup of scar tissue in the lungs of people with idiopathic pulmonary fibrosis (IPF). Ten participants took either the drug or a placebo pill daily for 12 weeks. Researchers used special PET/MRI scans to mea…

This study tested the safety and correct dosage of an experimental drug called PLN-74809 in people with primary sclerosing cholangitis (PSC), a rare disease that scars the liver's bile ducts. 121 participants received either the drug or a placebo for 12 to 48 weeks to see how the…